1.
Pemmaraju N, Lane AA. Response to Comment on: “First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level”. Haematologica; https://doi.org/10.3324/haematol.2026.302103 [Early view].